Advertisement
Roche
Roche

HPV DNA and cervical cancer

Consider quantifying levels of HPV DNA in women at high risk of cervical cancer.

June 26, 2000

NEW YORK, June 26 (Praxis Press) Infection with certain strains of human papillomavirus (HPV) increases the risk of cervical cancer, but the relationship between viral load and development of cancer is unclear. Two independent studies evaluated this relationship by performing nested case-control studies of women participating in cytological screening in Sweden. One group found that about 25% of women infected with a high HPV 16 load before age 25 years developed cervical carcinoma in situ within 15 years. The other study found that women with the 20% highest amount of HPV 16 DNA were at a 60-fold higher risk of developing cervical carcinoma in situ compared with women negative for HPV 16. Use of a quantitative HPV test in addition to current cytological screening could identify women at high risk of developing cervical cancer.

Advertisement

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
Mettler Toledo
BD Biosciences
BD Biosciences